Graham Cooke is a clinician scientist based within the Division of Infectious Diseases at the Wright-Fleming Institute. He trained in General Medicine and Infectious Diseases, working in Oxford, London and South Africa. Prior to taking up his current position, he was based at the Africa Centre for Health and Population Studies in KwaZulu-Natal.
His current work is focussed on stratified/precision medicine in infection, particularly HIV and viral hepatitis.
Funding: NIHR, MRC, Royal Society, EU, Treatment Action Group, Médecins sans Frontières, WHO StopTB, BRC Imperial College
Follow on twitter: @grahamscooke
et al., 2016, Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis, Clinical Infectious Diseases, Vol:62, ISSN:1058-4838, Pages:683-694
et al., 2015, Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response, Clinical Infectious Diseases, Vol:61, ISSN:1058-4838, Pages:730-740
et al., 2015, Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis, Lancet Infectious Diseases, Vol:15, ISSN:1473-3099, Pages:819-824
et al., 2015, Minimum Target Prices for Production of Direct-Acting Antivirals and Associated Diagnostics to Combat Hepatitis C Virus, Hepatology, Vol:61, ISSN:1527-3350, Pages:1174-1182
et al., 2015, Global Distribution and Prevalence of Hepatitis C Virus Genotypes, Hepatology, Vol:61, ISSN:0270-9139, Pages:77-87
Hill A, Cooke G, 2014, Hepatitis C can be cured globally, but at what cost?, Science, Vol:345, ISSN:0036-8075, Pages:141-142